Tag: pharmaceuticals
-

Report – 289 Cell and Gene Therapies in Development
A report by a pharmaceutical industry organization says nearly 300 new therapies that transfer live cells or genes as treatments for disease are in clinical trials or being reviewed by Food and Drug Administration.
-

FDA Identifies Database to Evaluate Precision Diagnostics
The Food and Drug Administration identified a public database of genomics and diseases as a resource to assess new diagnostics tests using genetic data for precision medicine.
-

Trial Results Show Gene Transfers Reverse Sickle Cell Disease
Results from the first 2 participants in a clinical trial show transferring healthy genes to patients with sickle cell disease reverses symptoms of the disease that continues for up to 1 year.
-

Janssen Licensing Cancer Antibodies in $1.8B Deal
An affiliate of drug maker Janssen Pharmaceutical is licensing a synthetic antibody to treat blood-related cancers from a developer of antibodies based on the immune system of llamas.
-

Trials OK’d for Inherited Eye Disease Therapy with Crispr
The company developing a treatment for a rare inherited eye disease using the genome editing technique Crispr received authorization from the Food and Drug Administration to begin clinical trials.
-

Project to Catalog Precision Lung Cancer Immunotherapies
A new research initiative in the U.K. is collecting and mapping precise combinations of therapies that invoke the immune system to treat lung cancer.
-

Nanotech Polymers Deliver More Effective Arthritis Therapy
A chemical engineering lab developed a process to help proteins combined with nanoscale polymers penetrate the cartilage in lab rodents and boost treatment for damage caused by osteoarthritis.
-

Company Formed to Advance Sickle Cell Gene Therapy
A Swiss medical technologies company and Cincinnati Children’s hospital in Ohio are starting a new enterprise to commercialize research on gene therapies for inherited blood disorders.
-

FDA Approves Biomarker-Targeting Cancer Drug
The Food and Drug Administration yesterday approved a treatment for solid tumor cancers that focuses on specific cancer-causing genetic conditions rather than location of the cancer in the body.
-

3-D Printed Scaffolds with Stem Cells, Sensors Studied to Repair Bones
A bioengineering lab at University of Arizona is researching new techniques with three-dimensional printing, stem cells, and sensors to repair severe bone fractures.